Board of Directors

Charles S. Duncker

Mr. Duncker spent the first 20 years of his career at Goldman Sachs Inc., retiring in 2001 as a Partner of that firm. Prior to that Mr. Duncker headed the Corporate Bond Department at Goldman, which included sales, trading and underwriting. Mr. Duncker is a graduate of Duke University where he sits on the Trinity College Board of Visitors and the Duke Financial Economics Steering Committee.

Ken Gall, PhD

Dr. Gall’s research interests are 3D printed metals and polymers, soft synthetic biomaterials, and biopolymers with structured surface porous networks. In addition to his research he has consulted for industry, the US Military and the US Intelligence Community, and served as an expert witness in multiple patent and product litigations. He founded two medical device start-up companies, MedShape and Vertera who have commercialized technologies in the orthopedic medical device space.

Greg Davis

Mr. Davis is a seasoned medical device executive with broad global and functional experience in finance, manufacturing, sales and general management. He is currently the EVP and Chief Operating Officer of Analytics 4 Life. He was also instrumental in the startup and management of a FDA-regulated, Class III manufacturing facility in Puerto Rico.

William Starling, Chairman of the Board

Mr. Starling is the Managing Director at Synergy Life Science Partners, LP, a $143 million Venture Capital Partnership and Chief Executive Officer of Synecor, LLC, a business generator of new Life Science companies based in Research Triangle Park. The start-up companies he has co-founded today represent over $4 billion in annual revenues.